Janny van den Eijnden-van Raaij is managing director of hDMT, the Netherlands Organ-on-Chip Consortium. She obtained her PhD as a biochemist at Radboud UMC Nijmegen in 1985. She then became group leader at the Hubrecht Institute Utrecht focusing on stem cells and growth factors in embryonic/ tumour development. In 2003 she became CEO at the Comprehensive Cancer Center South Eindhoven. Under her regime the cancer registry and epidemiological research department developed to the European leader in this field. In 2014 she switched to Organs-on-Chip (OoC) and established hDMT in 2015, a national public-private OoC Consortium of renowned scientists with various backgrounds, who work in academia, companies and UMCs. They share knowledge, expertise, ideas and facilities to develop human OoC models, that better recapitulate the human body and will reduce animal experiments. She built a broad international network on OoC in the H2020 ORCHID project and is board member (secretary/treasurer) and founding member of the European Organ-on-Chip Society (EUROoCS).